埼玉医科大学 · 医学部 / 医学研究科 · 講師

研究关键词EGFR-mutated non-small cell lung cancer・immune checkpoint inhibitors・platinum doublet chemotherapy・BRAF V600E resistance・osimertinib retreatment・dabrafenib plus trametinib・small-cell transformation・ocular cicatricial pemphigoid

以下为公开数据预览。个性化匹配理由、联系角度和保存能力需要登录后使用。

• Erlotinib-Induced Ocular Cicatricial Pemphigoid in EGFR-Mutated Non–Small Cell Lung Cancer: A Case Report2026 · Clinical Lung Cancer
• Efficacy of osimertinib resumption with dabrafenib and trametinib for elderly patients with EGFR-mutated lung adenocarcinoma harboring acquired BRAF V600E resistant mutation resistant to Osimertinib2025 · Japanese Journal of Clinical Oncology
• Efficacy of Immune Checkpoint Inhibitors in Combination With Platinum-Based Doublet Chemotherapy for Extensive Stage Small-Cell Lung Cancer Patients With Eastern Cooperative Oncology Group-Performance Status 2–3: A Single-Institution Retrospective Study2025 · Cancer Medicine
• Immunotherapy with radiotherapy for brain metastases in non-small cell lung cancer patients: NEJ0602024 · JTO Clinical and Research Reports

• 2024～2026 胸膜中皮腫におけるDishevelled-3抑制による抗腫瘍効果の増強因子の探索 基盤研究(C)2024 · 研究課題・受託研究・科研費
• 胸膜中皮腫におけるDishevelled-3抑制による抗腫瘍効果の増強因子の探索2024

• 官方个人主页
• ORCID